AKT1 and bladder transitional cell carcinoma: Numerous studies have shown that the aberrant activation of the PI3K/Akt signaling pathway was critical for the tumorigenesis and progression of BLCA and could enhance the malignant phenotypes of this disease (Courtney et al., 2010).